|
|
|
Volumn 9, Issue , 2013, Pages 273-282
|
|
Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
DRUG COMBINATION;
GLUCOSE BLOOD LEVEL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
PYRAZINE DERIVATIVE;
SIMVASTATIN;
SITAGLIPTIN;
TRIAZOLE DERIVATIVE;
BLOOD;
DRUG COMBINATION;
DRUG EFFECTS;
DYSLIPIDEMIAS;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERGLYCEMIA;
METABOLISM;
MORTALITY;
TREATMENT OUTCOME;
BIOLOGICAL MARKERS;
BLOOD GLUCOSE;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
DRUG COMBINATIONS;
DYSLIPIDEMIAS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERGLYCEMIA;
LIPIDS;
PYRAZINES;
SIMVASTATIN;
TREATMENT OUTCOME;
TRIAZOLES;
|
|
EID: 84891707701
PISSN: None
EISSN: 11782048
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (0)
|
